This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.

Headline

Long-term dual antiplatelet therapy cuts risk of recurrent heart attacks

Comment

While we used to treat arterial thrombo-embolic disease as a single entity (at least at the time when I was a medical SHO), it appears we have two trajectories with anti- platelet drugs( probably better in combination)are more for arterial thrombotic diseases and anti- coagulants(old or new) , are more for embolic diseases. Of course , they can co-exist.

Posted date

07 May 2015

Posted time

5:55pm

required
required
required